跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
优泽 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Levocetirizine Dihydrochloride Tablets
Approved
化学药品
Levocetirizine Dihydrochloride Tablets
UCB PHARMA SA
🇨🇳 National Medical Products Administration
Approval Date
May 15, 2025
Approval ID
81u8kAc7D5M
Company
UCB PHARMA SA
Type
化学药品
Approval Details
Approval Id
81u8kAc7D5M
Approval Number
国药准字HJ20150523
Generic Name
盐酸左西替利嗪片
Generic Name En
Levocetirizine Dihydrochloride Tablets
Trade Name
优泽
Drug Type
化学药品
Dosage Form
片剂
Strength
5mg
Reg Date
2025-05-15
Expired Date
2030-05-14
Company Name
UCB PHARMA SA
Production Company Name
UCB Farchim SA
Company Detail Path
/organization/ucb-pharma-sa
Production Company Detail Path
/organization/ucb-farchim-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 15, 2025
Approval ID
81u8kAc7D5M
Type
化学药品
Back to NMPA Approvals